Molecular mechanisms of congenital heart block

Experimental Cell Research

Volumn 325, Issue 1, 2014, Pages 2-9

  Ambrosi, Aurélie ^a   Sonesson, Sven Erik ^a   Wahren Herlenius, Marie ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Atrioventricular block; Autoantibodies; Congenital heart block; La SSB; MHC; Neonatal lupus erythematosus; Ro SSA

Indexed keywords

ANTIBODY; AUTOANTIBODY; CALCIUM; RO ANTIBODY;

CONGENITAL HEART BLOCK; GENETIC SUSCEPTIBILITY; HEART ATRIOVENTRICULAR NODE; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; INFLAMMATION; NONHUMAN; PATHOGENESIS; PREGNANCY; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW;

ATRIOVENTRICULAR BLOCK; AUTOANTIBODIES; CONGENITAL HEART BLOCK; LA/SSB; MHC; NEONATAL LUPUS ERYTHEMATOSUS; RO/SSA;

ANIMALS; APOPTOSIS; AUTOANTIBODIES; AUTOANTIGENS; HEART BLOCK; HUMANS; INFLAMMATION; MYOCARDIUM; RIBONUCLEOPROTEINS; RNA, SMALL CYTOPLASMIC;

EID: 84901821533     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2014.01.003     Document Type: Review

References (65)

1. Buyon J.P., Hiebert R., Copel J., Craft J., Friedman D., Katholi M., Lee L.A., Provost T.T., Reichlin M., Rider L., Rupel A., Saleeb S., Weston W.L., Skovron M.L. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J. Am. Coll. Cardiol. 1998, 31:1658-1666.
2. Eronen M., Siren M.K., Ekblad H., Tikanoja T., Julkunen H., Paavilainen T. Short- and long-term outcome of children with congenital complete heart block diagnosed in utero or as a newborn. Pediatrics 2000, 106:86-91.
3. Zhao H., Cuneo B.F., Strasburger J.F., Huhta J.C., Gotteiner N.L., Wakai R.T. Electrophysiological characteristics of fetal atrioventricular block. J. Am. Coll. Cardiol. 2008, 51:77-84.
4. Izmirly P.M., Saxena A., Kim M.Y., Wang D., Sahl S.K., Llanos C., Friedman D., Buyon J.P. Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus. Circulation 2011, 124:1927-1935.
5. Buyon J.P. Congenital complete heart block. Lupus 1993, 2:291-295.
6. Julkunen H., Kurki P., Kaaja R., Heikkila R., Immonen I., Chan E.K., Wallgren E., Friman C. Isolated congenital heart block. Long-term outcome of mothers and characterization of the immune response to SS-A/Ro and to SS-B/La. Arthritis Rheum. 1993, 36:1588-1598.
7. Salomonsson S., Dorner T., Theander E., Bremme K., Larsson P., Wahren-Herlenius M. A serologic marker for fetal risk of congenital heart block. Arthritis Rheum. 2002, 46:1233-1241.
8. Brucato A., Frassi M., Franceschini F., Cimaz R., Faden D., Pisoni M.P., Muscara M., Vignati G., Stramba-Badiale M., Catelli L., Lojacono A., Cavazzana I., Ghirardello A., Vescovi F., Gambari P.F., Doria A., Meroni P.L., Tincani A. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum. 2001, 44:1832-1835.
9. Salomonsson S., Ottosson L., Safsten P., Hof D., Brauner H., Sunnerhagen M., Raats J., Wahren-Herlenius M. Cloning and characterization of two human Ro52-specific monoclonal autoantibodies directed towards a domain associated with congenital heart block. J. Autoimmun. 2004, 22:167-177.
10. Ottosson L., Salomonsson S., Hennig J., Sonesson S.E., Dorner T., Raats J., Kuchroo V.K., Sunnerhagen M., Wahren-Herlenius M. Structurally derived mutations define congenital heart block-related epitopes within the 200-239 amino acid stretch of the Ro52 protein. Scand. J. Immunol. 2005, 61:109-118.
11. Strandberg L., Winqvist O., Sonesson S.E., Mohseni S., Salomonsson S., Bremme K., Buyon J.P., Julkunen H., Wahren-Herlenius M. Antibodies to amino acid 200-239 (p200) of Ro52 as serological markers for the risk of developing congenital heart block. Clin. Exp. Immunol. 2008, 154:30-37.
12. Jaeggi E., Laskin C., Hamilton R., Kingdom J., Silverman E. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants. J. Am. Coll. Cardiol. 2010, 55:2778-2784.
13. Solomon D.G., Rupel A., Buyon J.P. Birth order, gender and recurrence rate in autoantibody-associated congenital heart block: implications for pathogenesis and family counseling. Lupus 2003, 12:646-647.
14. Julkunen H., Eronen M. The rate of recurrence of isolated congenital heart block: a population-based study. Arthritis Rheum. 2001, 44:487-488.
15. Llanos C., Izmirly P.M., Katholi M., Clancy R.M., Friedman D.M., Kim M.Y., Buyon J.P. Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal/fetal risk factors. Arthritis Rheum. 2009, 60:3091-3097.
16. Ambrosi A., Salomonsson S., Eliasson H., Zeffer E., Skog A., Dzikaite V., Bergman G., Fernlund E., Tingstrom J., Theander E., Rydberg A., Skogh T., Ohman A., Lundstrom U., Mellander M., Winqvist O., Fored M., Ekbom A., Alfredsson L., Kallberg H., Olsson T., Gadler F., Jonzon A., Kockum I., Sonesson S.E., Wahren-Herlenius M. Development of heart block in children of SSA/SSB-autoantibody-positive women is associated with maternal age and displays a season-of-birth pattern. Ann. Rheum. Dis. 2012, 71:334-340.
17. Strandberg L., Salomonsson S., Bremme K., Sonesson S., Wahren-Herlenius M. Ro52, Ro60 and La IgG autoantibody levels and Ro52 IgG subclass profiles longitudinally throughout pregnancy in congenital heart block risk pregnancies. Lupus 2006, 15:346-353.
18. Litsey S.E., Noonan J.A., O'Connor W.N., Cottrill C.M., Mitchell B. Maternal connective tissue disease and congenital heart block. Demonstration of immunoglobulin in cardiac tissue. N. Engl. J. Med. 1985, 312:98-100.
19. Lee L.A., Coulter S., Erner S., Chu H. Cardiac immunoglobulin deposition in congenital heart block associated with maternal anti-Ro autoantibodies. Am. J. Med. 1987, 83:793-796.
20. Espinosa A., Zhou W., Ek M., Hedlund M., Brauner S., Popovic K., Horvath L., Wallerskog T., Oukka M., Nyberg F., Kuchroo V.K., Wahren-Herlenius M. The Sjogren's syndrome-associated autoantigen Ro52 is an E3 ligase that regulates proliferation and cell death. J. Immunol. 2006, 176:6277-6285.
21. Espinosa A., Dardalhon V., Brauner S., Ambrosi A., Higgs R., Quintana F.J., Sjostrand M., Eloranta M.L., Ni Gabhann J., Winqvist O., Sundelin B., Jefferies C.A., Rozell B., Kuchroo V.K., Wahren-Herlenius M. Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway. J. Exp. Med. 2009, 206:1661-1671.
22. Yoshimi R., Chang T.H., Wang H., Atsumi T., Morse H.C., Ozato K. Gene disruption study reveals a nonredundant role for TRIM21/Ro52 in NF-kappaB-dependent cytokine expression in fibroblasts. J. Immunol. 2009, 182:7527-7538.
23. Wu C., Orozco C., Boyer J., Leglise M., Goodale J., Batalov S., Hodge C.L., Haase J., Janes J., Huss J.W., Su A.I. BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol. 2009, 10:R130.
24. Chen X., Wolin S.L. The Ro 60kDa autoantigen: insights into cellular function and role in autoimmunity. J. Mol. Med. 2004, 82:232-239.
25. Casciola-Rosen L.A., Anhalt G., Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 1994, 179:1317-1330.
26. Miranda M.E., Tseng C.E., Rashbaum W., Ochs R.L., Casiano C.A., Di Donato F., Chan E.K., Buyon J.P. Accessibility of SSA/Ro and SSB/La antigens to maternal autoantibodies in apoptotic human fetal cardiac myocytes. J. Immunol. 1998, 161:5061-5069.
27. Reed J.H., Neufing P.J., Jackson M.W., Clancy R.M., Macardle P.J., Buyon J.P., Gordon T.P. Different temporal expression of immunodominant Ro60/60kDa-SSA and La/SSB apotopes. Clin. Exp. Immunol. 2007, 148:153-160.
28. Clancy R.M., Kapur R.P., Molad Y., Askanase A.D., Buyon J.P. Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage/fibroblast crosstalk in the pathologic cascade leading to congenital heart block. Arthritis Rheum. 2004, 50:173-182.
29. Miranda-Carus M.E., Askanase A.D., Clancy R.M., Di Donato F., Chou T.M., Libera M.R., Chan E.K., Buyon J.P. Anti-SSA/Ro and anti-SSB/La autoantibodies bind the surface of apoptotic fetal cardiocytes and promote secretion of TNF-alpha by macrophages. J. Immunol. 2000, 165:5345-5351.
30. Clancy R.M., Askanase A.D., Kapur R.P., Chiopelas E., Azar N., Miranda-Carus M.E., Buyon J.P. Transdifferentiation of cardiac fibroblasts, a fetal factor in anti-SSA/Ro-SSB/La antibody-mediated congenital heart block. J. Immunol. 2002, 169:2156-2163.
31. Reed J.H., Sim S., Wolin S.L., Clancy R.M., Buyon J.P. Ro60 requires Y3 RNA for cell surface exposure and inflammation associated with cardiac manifestations of neonatal lupus. J. Immunol. 2013, 191:110-116.
32. Clancy R.M., Neufing P.J., Zheng P., O'Mahony M., Nimmerjahn F., Gordon T.P., Buyon J.P. Impaired clearance of apoptotic cardiocytes is linked to anti-SSA/Ro and -SSB/La antibodies in the pathogenesis of congenital heart block. J. Clin. Invest. 2006, 116:2413-2422.
33. Boutjdir M., Chen L., Zhang Z.H., Tseng C.E., DiDonato F., Rashbaum W., Morris A., el-Sherif N., Buyon J.P. Arrhythmogenicity of IgG and anti-52-kD SSA/Ro affinity-purified antibodies from mothers of children with congenital heart block. Circ. Res. 1997, 80:354-362.
34. Boutjdir M., Chen L., Zhang Z.H., Tseng C.E., El-Sherif N., Buyon J.P. Serum and immunoglobulin G from the mother of a child with congenital heart block induce conduction abnormalities and inhibit L-type calcium channels in a rat heart model. Pediatr. Res. 1998, 44:11-19.
35. Xiao G.Q., Hu K., Boutjdir M. Direct inhibition of expressed cardiac l- and t-type calcium channels by igg from mothers whose children have congenital heart block. Circulation 2001, 103:1599-1604.
36. Xiao G.Q., Qu Y., Hu K., Boutjdir M. Down-regulation of L-type calcium channel in pups born to 52kDa SSA/Ro immunized rabbits. FASEB J. 2001, 15:1539-1545.
37. Qu Y., Xiao G.Q., Chen L., Boutjdir M. Autoantibodies from mothers of children with congenital heart block downregulate cardiac L-type Ca channels. J. Mol. Cell. Cardiol. 2001, 33:1153-1163.
38. Qu Y., Baroudi G., Yue Y., Boutjdir M. Novel molecular mechanism involving alpha1D (Cav1.3) L-type calcium channel in autoimmune-associated sinus bradycardia. Circulation 2005, 111:3034-3041.
39. Strandberg L.S., Cui X., Rath A., Liu J., Silverman E.D., Liu X., Siragam V., Ackerley C., Su B.B., Yan J.Y., Capecchi M., Biavati L., Accorroni A., Yuen W., Quattrone F., Lung K., Jaeggi E.T., Backx P.H., Deber C.M., Hamilton R.M. Congenital heart block maternal sera autoantibodies target an extracellular epitope on the alpha1G T-type calcium channel in human fetal hearts. PLoS One 2013, 8:e72668.
40. Sonesson S.E., Salomonsson S., Jacobson L.-A., Bremme K., Wahren-Herlenius M. Signs of first degree heart block occurs in one third of fetuses of pregnant women with anti-SSA/Ro52 antibodies. Arthritis Rheum. 2004, 50:1253-1261.
41. Bergman G., Wahren-Herlenius M., Sonesson S.E. Diagnostic precision of Doppler flow echocardiography in fetuses at risk for atrioventricular block. Ultrasound Obstet. Gynecol. 2010, 36:561-566.
42. Julkunen H., Kaaja R., Wallgren E., Teramo K. Isolated congenital heart block: fetal and infant outcome and familial incidence of heart block. Obstet. Gynecol. 1993, 82:11-16.
43. Eronen M., Miettinen A., Walle T.K., Chan E.K., Julkunen H. Relationship of maternal autoimmune response to clinical manifestations in children with congenital complete heart block. Acta Paediatr. 2004, 93:803-809.
44. Salomonsson S., Dzikaite V., Zeffer E., Eliasson H., Ambrosi A., Bergman G., Fernlund E., Theander E., Ohman A., Rydberg A., Skogh T., Wallberg-Jonsson S., Elfving A., Fored M., Ekbom A., Lundstrom U., Mellander M., Winqvist O., Sonesson S.E., Gadler F., Jonzon A., Wahren-Herlenius M. A population-based investigation of the autoantibody profile in mothers of children with atrioventricular block. Scand. J. Immunol. 2011, 74:511-517.
45. Miranda-Carus M.E., Boutjdir M., Tseng C.E., DiDonato F., Chan E.K., Buyon J.P. Induction of antibodies reactive with SSA/Ro-SSB/La and development of congenital heart block in a murine model. J. Immunol. 1998, 161:5886-5892.
46. Strandberg L.S., Ambrosi A., Jagodic M., Dzikaite V., Janson P., Khademi M., Salomonsson S., Ottosson L., Klauninger R., Aden U., Sonesson S.E., Sunnerhagen M., de Graaf K.L., Kuchroo V.K., Achour A., Winqvist O., Olsson T., Wahren-Herlenius M. Maternal MHC regulates generation of pathogenic antibodies and fetal MHC-encoded genes determine susceptibility in congenital heart block. J. Immunol. 2010, 185:3574-3582.
47. Ambrosi A., Dzikaite V., Park J., Strandberg L., Kuchroo V.K., Herlenius E., Wahren-Herlenius M. Anti-Ro52 monoclonal antibodies specific for amino acid 200-239, but not other Ro52 epitopes, induce congenital heart block in a rat model. Ann. Rheum. Dis. 2012, 71:448-454.
48. Salomonsson S., Sonesson S.E., Ottosson L., Muhallab S., Olsson T., Sunnerhagen M., Kuchroo V.K., Thoren P., Herlenius E., Wahren-Herlenius M. Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block. J. Exp. Med. 2005, 201:11-17.
49. Mazel J.A., El-Sherif N., Buyon J., Boutjdir M. Electrocardiographic abnormalities in a murine model injected with IgG from mothers of children with congenital heart block. Circulation 1999, 99:1914-1918.
50. 2+ channels in cardiac pacemaker activity. Proc. Natl. Acad. Sci. USA 2003, 100:5543-5548.
51. Matthes J., Yildirim L., Wietzorrek G., Reimer D., Striessnig J., Herzig S. Disturbed atrio-ventricular conduction and normal contractile function in isolated hearts from Cav1.3-knockout mice. Naunyn Schmiedebergs Arch. Pharmacol. 2004, 369:554-562.
52. Mangoni M.E., Couette B., Marger L., Bourinet E., Striessnig J., Nargeot J. Voltage-dependent calcium channels and cardiac pacemaker activity: from ionic currents to genes. Prog. Biophys. Mol. Biol. 2006, 90:38-63.
53. Karnabi E., Qu Y., Wadgaonkar R., Mancarella S., Yue Y., Chahine M., Clancy R.M., Buyon J.P., Boutjdir M. Congenital heart block: identification of autoantibody binding site on the extracellular loop (domain I, S5-S6) of alpha(1D) L-type Ca channel. J. Autoimmun. 2010, 34:80-86.
54. Karnabi E., Qu Y., Mancarella S., Boutjdir M. Rescue and worsening of congenital heart block-associated electrocardiographic abnormalities in two transgenic mice. J. Cardiovasc. Electrophysiol. 2011, 22:922-930.
55. Lazzerini P.E., Capecchi P.L., Laghi-Pasini F. Anti-Ro/SSA antibodies and cardiac arrhythmias in the adult: facts and hypotheses. Scand. J. Immunol. 2010, 72:213-222.
56. Bergman G., Eliasson H., Bremme K., Wahren-Herlenius M., Sonesson S.E. Anti-Ro52/SSA antibody-exposed fetuses with prolonged atrioventricular time intervals show signs of decreased cardiac performance. Ultrasound Obstet. Gynecol. 2009, 34:543-549.
57. Clancy R.M., Buyon J.P., Ikeda K., Nozawa K., Argyle D.A., Friedman D.M., Chan E.K. Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects. Arthritis Rheum. 2005, 52:3079-3086.
58. Tunks R.D., Clowse M.E., Miller S.G., Brancazio L.R., Barker P.C. Maternal autoantibody levels in congenital heart block and potential prophylaxis with antiinflammatory agents. Am. J. Obstet. Gynecol. 2013, 208(64):e61-e67.
59. Gordon P., Khamashta M.A., Rosenthal E., Simpson J.M., Sharland G., Brucato A., Franceschini F., De Bosschere K., Meheus L., Meroni P.L., Hughes G.R., Buyon J. Anti-52kDa Ro, anti-60kDa Ro, and anti-La antibody profiles in neonatal lupus. J. Rheumatol. 2004, 31:2480-2487.
60. Clancy R.M., Backer C.B., Yin X., Kapur R.P., Molad Y., Buyon J.P. Cytokine polymorphisms and histologic expression in autopsy studies: contribution of TNF-alpha and TGF-beta 1 to the pathogenesis of autoimmune-associated congenital heart block. J. Immunol. 2003, 171:3253-3261.
61. Meisgen S., Östberg T., Salomonsson S., Ding B., Eliasson H., Mälarstig A., Alfredsson L., Klareskog L., Hamsten A., Olsson T., Axelsson T., Group T.S.C.H., Gadler F., Jonzon A., Sonesson S.-E., Kockum I., Wahren-Herlenius M. The HLA locus contains novel foetal susceptibility alleles for congenital heart block with significant paternal influence. J. Intern. Med. 2013, Dec 20 (Epub ahead of print). 10.1111/joim.12179.
62. Clancy R.M., Marion M.C., Kaufman K.M., Ramos P.S., Adler A., Harley J.B., Langefeld C.D., Buyon J.P. Genome-wide association study of cardiac manifestations of neonatal lupus identifies candidate loci at 6p21 and 21q22. Arthritis Rheum. 2010, 62:3415-3424.
63. Reed J.H., Clancy R.M., Purcell A.W., Kim M.Y., Gordon T.P., Buyon J.P. Beta2-glycoprotein I and protection from anti-SSA/Ro60-associated cardiac manifestations of neonatal lupus. J. Immunol. 2011, 187:520-526.
64. Karnabi E., Qu Y., Yue Y., Boutjdir M. Calreticulin negatively regulates the surface expression of Cav1.3 L-type calcium channel. Biochem. Biophys. Res. Commun. 2013, 437:497-501.
65. Bergman G., Eliasson H., Mohlkert L.A., Wahren-Herlenius M., Sonesson S.E. Progression to first-degree heart block in preschool children exposed in utero to maternal anti-SSA/Ro52 autoantibodies. Acta Paediatr. 2012, 101:488-493.